Showing results (281-290 of 355) with videos related to

Sort By:
Pageof 36
NEJM Evidence|February 6, 2024
Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER TrialsToru Kondo, Samvel B Gasparyan, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|January 15, 2025
Initial Decline in Glomerular Filtration Rate With Finerenone in HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HFShingo Matsumoto, Pardeep S Jhund, Alasdair D Henderson, et al.
JAMA Cardiology|November 17, 2024
Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialMisato Chimura, Xiaowen Wang, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|August 23, 2023
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart FailureToru Kondo, Xiaowen Wang, Mingming Yang, et al.
Journal of the American College of Cardiology|December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionMikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Circulation. Heart Failure|February 22, 2023
A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort StudyNiklas Dyrby Johansen, Muthiah Vaduganathan, Deewa Zahir, et al.
Journal of the American College of Cardiology|April 30, 2025
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled AnalysisMaria A Pabon, Gerasimos Filippatos, Brian L Claggett, et al.
European Journal of Heart Failure|April 29, 2025
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HFToru Kondo, Pardeep S Jhund, Alasdair D Henderson, et al.
JAMA Cardiology|March 29, 2025
Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical TrialShingo Matsumoto, Alasdair D Henderson, Pardeep S Jhund, et al.
JAMA Cardiology|May 21, 2025
Finerenone in Heart Failure With Improved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialMaria A Pabon, Orly Vardeny, Muthiah Vaduganathan, et al.
Pageof 36